Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 23 Show results per page	View Search Criteria \| Help With Results


1.		CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				18 and over				Pharmaceutical / Industry				08-0106 NCT00748085


2.		Vorinostat (MK0683, SAHA) Versus Placebo in Advanced Malignant Pleural Mesothelioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				2005_010 MK0683-014, NCT00128102


3.		Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With MPM

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Other				MCC-14896 USFIRB#105715, AVF3483s, NCT00604461

Last Modified: 11/2/2007 First Published: 1/1/1999


4.		Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Stage IV Mesothelioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				1 and over				Other				BC-MA-2 NCT00003508

Last Modified: 5/13/2008 First Published: 3/24/2006


5.		Phase II Study of AZD2171 in Patients With Malignant Pleural, Peritoneal, or Tunica Vaginalis Mesothelioma That is Not Amenable to Curative Surgery

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				18 and over				NCI				UCCRC-14203B NCI-7103, 7103, NCT00309946


6.		Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				AVF3442S NCT00295503

Last Modified: 10/9/2008 First Published: 4/6/2007


7.		Phase II Study of Pazopanib Hydrochloride in Patients With Malignant Pleural Mesothelioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				18 and over				NCI				NCCTG-N0623 N0623, NCT00459862

Last Modified: 8/26/2008 First Published: 7/24/2007


8.		Phase II Study of Dasatinib in Patients With Previously Treated Malignant Mesothelioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				18 and over				NCI				CALGB-30601 CALGB-30601, CALGB 30601, NCT00509041


9.		An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				TL139204 NCT00685204

Last Modified: 9/19/2007 First Published: 7/1/2002


10.		Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion in Subjects with Pulmonary and Pleural Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				NCI				NCI-02-C-0205J NCI-5270, 5270, NCT00041158

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute